Data Use Application 010
Lead applicant organisation name
Name of the legal entity that signs the contract to access the data.
University of Birmingham (UoB). Applicant: David Brind, Research student PhD
Project title
The title of the project/research study request that the applicant is investigating through the use of health data.
Exploration of associations between retinal imaging and renal disease.
Lay summary
A concise and clear description of the project. This should outline the problem, objective and the expected outcomes in language that is understandable to the general public.
This project aims to improve our capacity to identify patients at risk of end-stage renal disease within the next five years. Currently chronic kidney disease (CKD) has a high prevalence in the UK and it is estimated to affect around 10% of the population, rising to 20% in those above the age of 80. Prior studies from the NHS indicate that between 900,000 and 1.8 million people have undiagnosed CKD in the moderate to severe stages 3-5. CKD can be difficult to diagnose as it requires blood testing to confirm diagnosis. However, patients in the early stages are more likely to be asymptomatic until later stages of the disease.
This research uses machine learning techniques to identify links between routinely captured retinal imaging and a patient’s current kidney health. Computer vision techniques are used to unlock features in these retinal scans that can be used to identify those at risk of end-stage renal disease. The outputs would be robustly compared to the current standard – kidney risk failure equation – to verify that the research methods deployed do not introduce significant bias. The outcome of this project will be a tool that can identify those at risk of renal decline within routine care, improving standards of treatment and quality of life for patients with CKD.
Public benefit statement
A description in plain English of the anticipated outcomes, or impact of project on the general public.
The research could prove instrumental in the improvement of quality of life for patients with CKD. Identifying those at risk of end-stage renal disease will allow clinicians and patients to be proactive in their care. The project output could result in more CKD patients receiving earlier prognosis and avoiding dialysis and/or kidney transplantation. Furthermore, it could enable CKD patients to experience a better quality of life for longer.
Latest approval date
The last date the data access request for this project was approved by a data custodian.
25 March 2024
Dataset(s) name
The name of the dataset(s) being accessed.
Diabetic Eye Screening: the Birmingham, Solihull and Black Country, linked with bespoke renal disease data
Access type
Determines whether the data will be accessed with an Trusted Research Environment (TRE) or via data release.
Data Licence Agreement. Data accessed within UHB Trust on premises digital environment
Data sensitivity level
The level of identifiability of the data being accessed, as defined by Understanding Patient Data.
Anonymised